Ethosuximide 59762-2350
Product NDC
59762-2350- Manufacturer
- Mylan Pharmaceuticals Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 21, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA080258
Need to source Ethosuximide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ethosuximide | 250 mg/5mL |
Drug Class
Anti-epileptic Agent [EPC]Anti-epileptic Agent [EPC]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-6) / 474 mL in 1 BOTTLE, PLASTIC
1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-7) / 474 mL in 1 BOTTLE, PLASTIC